학술논문
Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study
Document Type
Article
Source
In Value in Health March 2024
Subject
Language
ISSN
1098-3015